Abstract
A collagen network, composed largely of type I and III fibrillar collagens, is found in the heart’s interstitial space. This network has multiple functions, including the preservation of tissue architecture and chamber geometry. Given its tensile strength, type I collagen is a major determinant of tissue stiffness. Its disproportionate accumulation, expressed in morphological terms as tissue fibrosis, increases myocardial passive and active stiffness and contributes to ventricular diastolic and systolic dysfunction. Various animal models of cardiac fibrosis have been used to study its functional consequences and to elucidate factors regulating the cellular and molecular biology of fibrogenesis. Herein, we present our experience and findings with several models of cardiac fibrosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Laurent, G. J. (1987) Dynamic state of collagen: pathways of collagen degradation in vivo and their possible role in regulation of collagen mass. Am. J. Physiol. 252, C1–C9.
Docherty, A. J. and Murphy, G. (1990) The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann. Rheum. Dis. 49, 469–479.
Tyagi, S. C., Ratajska, A. and Weber, K. T. (1993) Myocardial matrix metalloproteinase(s): localization and activation. Mol. Cell. Biochem. 126, 49–59.
Weber, K. T., Sun, Y. and Katwa, L. C. (1997) Myofibroblasts and local angiotensin II in rat cardiac tissue repair. Int. J. Biochem. Cell Biol. 29, 31–42.
Jugdutt, B. I. and Amy, R. W. M. (1986) Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J. Am. Coll. Cardiol. 7, 91–102.
Brilla, C. G., Matsubara, L. S., and Weber, K. T. (1993) Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J. Mol. Cell. Cardiol. 25, 563–575.
Medugorac, I. (1980) Collagen content in different areas of normal and hypertrophied rat myocardium. Cardiovasc. Res. 14, 551–554.
Weber, K. T., Pick, R., Janicki, J. S., Gadodia, G., and Lakier, J. B. (1988) Inadequate collagen tethers in dilated cardiopathy. Am. Heart J. 116, 1641–1646.
Bishop, J., Greenbaum, J., Gibson, D., Yacoub, M., and Laurent, G. J. (1990) Enhanced deposition of predominantly type I collagen in myocardial disease. J. Mol. Cell. Cardiol. 22, 1157–1165.
Chapman, D., Weber, K. T., and Eghbali, M. (1990) Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Circ. Res. 67, 787–794.
Mukherjee, D. and Sen, S. (1990) Collagen phenotypes during development and regression of myocardial hypertrophy in spontaneously hypertensive rats. Circ. Res. 67, 1474–1480.
Pfeffer, M. A., Pfeffer, J. M., Fishbein, M. C., Fletcher, P. J., Spadaro, J., Kloner, R. A., and Braunwald, E. (1979) Myocardial infarct size and ventricular function in rats. Circ. Res. 44, 503–512.
Sun, Y. and Weber, K. T. (1994) Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc. Res. 28, 1623–1628.
Sun, Y., Zhang, J. Q., Zhang, J., and Lamparter, S. (2000) Cardiac remodeling by fibrous tissue after infarction in rats. J. Lab. Clin. Med. 135, 316–323.
Sun, Y., Cleutjens, J. P. M., Diaz-Arias, A. A., and Weber, K. T. (1994) Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. Cardiovasc. Rets. 28, 1423–1432.
Cleutjens, J. P. M., Kandala, J. C., Guarda, E., Guntaka, R. V., and Weber, K. T. (1995) Regulation of collagen degradation in the rat myocardium after infarction. J. Mol. Cell. Cardiol. 27, 1281–1292.
Peterson, J. T., Li, H., Dillon, L., and Bryant, J. W. (2000) Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Cardiovasc. Res. 46, 307–315.
Cleutjens, J. P. M., Verluyten, M. J. A., Smits, J. F. M., and Daemen, M. J. A. P. (1995) Collagen remodeling after myocardial infarction in the rat heart. Am. J. Pathol. 147, 325–338.
Sun, Y., Zhang, J. Q., Zhang, J., and Ramires, F. J. A. (1998) Angiotensin II, transforming growth factor-β1 and repair in the infarcted heart. J. Mol. Cell. Cardiol. 30, 1559–1569.
Wei, S., Chow, L. T., Shum, I. O., Qin, L., and Sanderson, J. E. (1999) Left and right ventricular collagen type I/III ratios and remodeling post-myocardial infarction. J. Cardiac Failure 5, 117–126.
Gideon, P. A., Warrington, K. J., Lu, L., Sun, Y., and Weber, K. T. (2003) Autoimmune lymphocyte response at sites remote to myocardial infarction [abstract]. Circulation 108, IV–69.
Sun, Y. and Weber, K. T. (1996) Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J. Mol. Cell. Cardiol. 28, 851–858.
Blankesteijn, W. M., Essers-Janssen, Y. P. G., Verluyten, M. J. A., Daemen, M. J. A. P., and Smits, J. F. M. (1997) A homologue of Drosophila tissue polarity gene frizzled is expressed in migrating myofibroblasts in the infarcted rat heart. Nat. Med. 3, 541–544.
Peterson, D. J., Ju, H., Hao, J., Panagia, M., Chapman, D. C., and Dixon, I. M. (1999) Expression of Gi-2α and Gsα in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc. Res. 41, 575–585.
Gabbiani, G., Hirschel, B. J., Ryan, G. B., Statkov, P. R., and Majno, G. (1972) Granulation tissue as a contractile organ. A study of structure and function. J. Exp. Med. 135, 719–734.
Yokozeki, M., Moriyama, K., Shimokawa, H., and Kuroda, T. (1997) Transforming growth factor-β1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro. Exp. Cell Res. 231, 328–336.
Khouw, I. M., van Wachem, P. B., Plantinga, J. A., Vujaskovic, Z., Wissink, M. J., de Leij, L. F., and van Luyn, M. J. (1999) TGF-β and βFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro. Biomaterials 20, 1815–1822.
Evans, R. A., Tian, Y. C., Steadman, R., and Phillips, A. O. (2003) TGF-β1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp. Cell Res. 282, 90–100.
Willems, I. E. M. G., Havenith, M. G., De Mey, J. G. R., and Daemen, M. J. A. P. (1994) The α-smooth muscle actin-positive cells in healing human myocardial scars. Am. J. Pathol. 145, 868–875.
Sun, Y., Zhang, J., Zhang, J. Q., and Ramires, F. J. A. (2000) Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats. Hypertension 35, 1078–1084.
Ou, R., Sun, Y., Ganjam, V. K., and Weber, K. T. (1996) In situ production of angiotensin II by fibrosed rat pericardium. J. Mol. Cell. Cardiol. 28, 1319–1327.
Yamagishi, H., Kim, S., Nishikimi, T., Takeuchi, K., and Takeda, T. (1993) Contribution of cardiac renin-angiotensin system to ventricular remodelling in myocardial-infarcted rats. J. Mol. Cell. Cardiol. 25, 1369–1380.
Jugdutt, B. I., Humen, D. P., Khan, M. I., and Schwarz-Michorowski, B. L. (1992) Effect of left ventricular unloading with captopril on remodeling and function during healing of anterior transmural myocardial infarction in the dog. Can. J. Cardiol. 8, 151–163.
Jugdutt, B. I., Khan, M. I., Jugdutt, S. J., and Blinston, G. E. (1995) Effect of enalapril on ventricular remodeling and function during healing after anterior myocardial infarction in the dog. Circulation 91, 802–812.
Michel, J.-B., Lattion, A.-L., Salzmann, J.-L., Cerol, M. L., Philippe, M., Camilleri, J.-P., and Corvol, P. (1988) Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ. Res. 62, 641–650.
van Krimpen, C., Schoemaker, R. G., Cleutjens, J. P. M., Smits, J. F. M., Struyker-Boudier, H. A. J., Bosman, F. T., and Daemen, M. J. A. P. (1991) Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res. Cardiol. 86, 149–155.
Smits, J. F. M., van Krimpen, C., Schoemaker, R. G., Cleutjens, J. P. M., and Daemen, M. J. A. P. (1992) Angiotensin II receptor blockade after myocardial infarction in rats: effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content. J. Cardiovasc. Pharmacol. 20, 772–778.
Hodsman, G. P., Kohzuki, M., Howes, L. G., Sumithran, E., Tsunoda, K., and Johnston, C. I. (1988) Neurohumoral responses to chronic myocardial infarction in rats. Circulation 78, 376–381.
Hirsch, A. T., Talsness, C. E., Schunkert, H., Paul, M., and Dzau, V. J. (1991) Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure. Circ. Res. 69, 475–482.
Sun, Y., Ratajska, A., Zhou, G., and Weber, K. T. (1993) Angiotensin converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J. Lab. Clin. Med. 122, 395–403.
Young, M., Fullerton, M., Dilley, R., and Funder, J. (1994) Mineralocorticoids, hypertension, and cardiac fibrosis. J. Clin. Invest. 93, 2578–2583.
Sun, Y., Ramires, F. J. A., and Weber, K. T. (1997) Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc. Res. 35, 138–147.
Campbell, S. E., Janicki, J. S., and Weber, K. T. (1995) Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J. Mol. Cell. Cardiol. 27, 1545–1560.
Sun, Y., Zhang, J., Lu, L., Chen, S. S., Quinn, M. T., and Weber, K. T. (2002) Aldosterone-induced inflammation in the rat heart. iRole of oxidative stress. Am. J. Pathol. 161, 1773–1781.
Ahokas, R. A., Warrington, K. J., Gerling, I. C., et al. (2003) Aldosteronism and peripheral blood mononuclear cell activation. A neuroendocrine-immune interface. Circ. Res. 93, e124–e135.
Gerling, I. C., Sun, Y., Ahokas, R. A., Wodi, L. A., et al. (2003) Aldosteronism: an immunostimulatory state precedes the proinflammatory/fibrogenic cardiac phenotype. Am. J. Physiol. Heart Circ. Physiol. 285, H813–H821.
Rousseau-Plasse, A., Lenfant, M., and Potier, P. (1996) Catabolism of the hemoregulatory peptide N-Acetyl-Ser-Asp-Lys-Pro: a new insight into the physiological role of the angiotensin-I-converting enzyme N-active site. Bioorg. Med. Chem. 4, 1113–1119.
Sun, Y., Zhang, J., Lu, L., Bedigian, M. P., Robinson, A. D., and Weber, K. T. (2004)Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart. J. Lab. Clin. Med., in press.
Robert, V., Heymes, C., Silvestre, J.-S., Sabri, A., Swynghedauw, B., and Delcayre, C. (1999) Angiotensin AT1 receptor subtype as a cardiac target of aldosterone. Role in aldosterone-salt-induced fibrosis. Hypertension 33, 981–986.
Tan, L. B., Jalil, J. E., Pick, R., Janicki, J. S., and Weber, K. T. (1991) Cardiac myocyte necrosis induced by angiotensin II. Circ. Res. 69, 1185–1195.
Sun, Y., Ratajska, A., and Weber, K. T. (1995) Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J. Lab. Clin. Med. 126, 95–101.
Brilla, C. G., Pick, R., Tan, L. B., Janicki, J. S., and Weber, K. T. (1990) Remodeling of the rat right and left ventricle in experimental hypertension. Circ. Res. 67, 1355–1364.
Everett, A. D., Tufro-McReddie, A., Fisher, A., and Gomez, R. A. (1994) Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-β1 expression. Hypertension 23, 587–592.
Rupérez, M., Ruiz-Ortega, M., Esteban, V., Lorenzo, O., Mezzano, S., Plaza, J. J., and Egido, J. ((2003) Angiotensin II increases connective tissue growth factor in the kidney. Am. J. Pathol. 163, 1937–1947.
Wang, H. D., Xu, S., Johns, D. G., Du, Y., Quinn, M. T., Cayatte, A. J., and Cohen, R. A. (2001) Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ. Res. 88, 947–953.
Harrison, D. G., Cai, H., Landmesser, U., and Griendling, K. K. (2003) Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 4, 51–61.
Barnes, P. J. and Karin, M. (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066–1071.
Muller, D. N., Dechend, R., Mervaala, E. M., et al. (2000) NF-κB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 35, 193–201.
Lijnen, P. J., Petrov, V. V., and Fagard, R. H. (2001) Angiotensin II-induced stimulation of collagen secretion and production in cardiac fibroblasts is mediated via angiotensin II subtype 1 receptors. J. Renin Angiotensin Aldosterone Syst. 2, 117–122.
Lijnen, P. J. and Petrov, V. V. (2003) Role of intracardiac renin-angiotensin-aldosterone system in extracellular matrix remodeling. Methods Find. Exp. Clin. Pharmacol. 25, 541–564.
Sun, Y. and Weber, K. T. (1996) Angiotensin-converting enzyme and wound healing in diverse tissues of the rat. J. Lab. Clin. Med. 127, 94–101.
Acknowledgments
This work was supported in part by National Institutes of Health National Heart, Lung, and Blood Institute grants R01-HL67888 (to Y.S.), and R01-HL62229 (to K.T.W.), and grants from the University of Tennessee Health Science Center Center of Excellence in Connective Tissue Diseases (to Y.S. and K.T.W.).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Sun, Y., Weber, K.T. (2005). Animal Models of Cardiac Fibrosis. In: Varga, J., Brenner, D.A., Phan, S.H. (eds) Fibrosis Research. Methods in Molecular Medicine, vol 117. Humana Press. https://doi.org/10.1385/1-59259-940-0:273
Download citation
DOI: https://doi.org/10.1385/1-59259-940-0:273
Publisher Name: Humana Press
Print ISBN: 978-1-58829-479-1
Online ISBN: 978-1-59259-940-0
eBook Packages: Springer Protocols